DK160098C - Tricycliske oxindolcarboxamid-derivater - Google Patents

Tricycliske oxindolcarboxamid-derivater

Info

Publication number
DK160098C
DK160098C DK382685A DK382685A DK160098C DK 160098 C DK160098 C DK 160098C DK 382685 A DK382685 A DK 382685A DK 382685 A DK382685 A DK 382685A DK 160098 C DK160098 C DK 160098C
Authority
DK
Denmark
Prior art keywords
sub
tricyclic
oxindolcarboxamide
derivatives
het
Prior art date
Application number
DK382685A
Other languages
English (en)
Other versions
DK160098B (da
DK382685A (da
DK382685D0 (da
Inventor
Jr Lawrence Sherman Melvin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK382685D0 publication Critical patent/DK382685D0/da
Publication of DK382685A publication Critical patent/DK382685A/da
Publication of DK160098B publication Critical patent/DK160098B/da
Application granted granted Critical
Publication of DK160098C publication Critical patent/DK160098C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Filling Or Discharging Of Gas Storage Vessels (AREA)
  • Medicinal Preparation (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
DK382685A 1984-08-24 1985-08-23 Tricycliske oxindolcarboxamid-derivater DK160098C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8401371 1984-08-24
PCT/US1984/001371 WO1986001510A1 (en) 1984-08-24 1984-08-24 Tricyclic oxindole antiinflammatory agents

Publications (4)

Publication Number Publication Date
DK382685D0 DK382685D0 (da) 1985-08-23
DK382685A DK382685A (da) 1986-02-25
DK160098B DK160098B (da) 1991-01-28
DK160098C true DK160098C (da) 1991-06-24

Family

ID=22182243

Family Applications (1)

Application Number Title Priority Date Filing Date
DK382685A DK160098C (da) 1984-08-24 1985-08-23 Tricycliske oxindolcarboxamid-derivater

Country Status (21)

Country Link
US (1) US4695571A (da)
EP (1) EP0173520B1 (da)
JP (1) JPS6157554A (da)
KR (1) KR870001144B1 (da)
AT (1) ATE49211T1 (da)
AU (1) AU553859B2 (da)
CA (1) CA1244427A (da)
DE (1) DE3575140D1 (da)
DK (1) DK160098C (da)
EG (1) EG17287A (da)
ES (2) ES8704497A1 (da)
FI (1) FI79319C (da)
GR (1) GR852026B (da)
HU (2) HU203238B (da)
IE (1) IE58739B1 (da)
IL (1) IL76175A (da)
PH (1) PH23065A (da)
PL (2) PL147395B1 (da)
PT (1) PT81004B (da)
WO (1) WO1986001510A1 (da)
ZA (1) ZA856403B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531678A1 (de) * 1985-09-05 1987-03-12 Boehringer Mannheim Gmbh Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS63223492A (ja) * 1987-03-11 1988-09-16 Okawara Mfg Co Ltd 熱交換器
WO1990008146A1 (en) * 1989-01-10 1990-07-26 Pfizer Inc. Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides
HU215112B (hu) * 1989-01-10 1998-12-28 Pfizer Inc. Eljárás gyulladáscsökkentő 1-heteroaril-3-acil-2-oxindol-származékok előállítására
US5300655A (en) * 1989-04-18 1994-04-05 Pfizer Inc. 2-carboxy-thiophene derivatives
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
JPH04217684A (ja) * 1990-05-30 1992-08-07 Shionogi & Co Ltd アルド−ス還元酵素阻害物質
DE4027592A1 (de) * 1990-08-31 1992-03-05 Beiersdorf Ag Neue pyrrolobenzimidazole, imidazobenzoxazinone und imidazochinolone, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
WO2005041957A1 (en) * 2003-10-29 2005-05-12 Pfizer Products Inc. Oxindole derivatives and their use as phosphodiesterase type 2 inhibitors
PT1889198E (pt) 2005-04-28 2015-03-06 Proteus Digital Health Inc Sistema fármaco-informático
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
NZ596876A (en) 2009-05-06 2014-01-31 Lab Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756447A (fr) * 1969-10-15 1971-03-22 Pfizer Oxindolecarboxamides
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
US4644005A (en) * 1984-10-31 1987-02-17 Pfizer Inc. Oxindole antiinflammatory agents

Also Published As

Publication number Publication date
JPS6157554A (ja) 1986-03-24
WO1986001510A1 (en) 1986-03-13
ES8706116A1 (es) 1987-06-01
HU902020D0 (en) 1990-07-28
FI861704A (fi) 1986-04-23
ES8704497A1 (es) 1987-04-01
ZA856403B (en) 1987-04-29
PT81004A (en) 1985-09-01
KR870001144B1 (ko) 1987-06-11
GR852026B (da) 1985-12-19
EP0173520A2 (en) 1986-03-05
DK160098B (da) 1991-01-28
IL76175A0 (en) 1985-12-31
FI79319C (fi) 1989-12-11
PL147395B1 (en) 1989-05-31
ATE49211T1 (de) 1990-01-15
CA1244427A (en) 1988-11-08
AU4663785A (en) 1986-02-27
JPH0450316B2 (da) 1992-08-13
FI79319B (fi) 1989-08-31
IE58739B1 (en) 1993-11-03
HU203238B (en) 1991-06-28
FI861704A0 (fi) 1986-04-23
ES552044A0 (es) 1987-06-01
EP0173520A3 (en) 1986-05-14
HU203350B (en) 1991-07-29
KR870002143A (ko) 1987-03-30
PL147393B1 (en) 1989-05-31
AU553859B2 (en) 1986-07-31
US4695571A (en) 1987-09-22
PT81004B (pt) 1987-12-30
DK382685A (da) 1986-02-25
PL255089A1 (en) 1986-12-30
DK382685D0 (da) 1985-08-23
IL76175A (en) 1989-08-15
EP0173520B1 (en) 1990-01-03
HUT47580A (en) 1989-03-28
PH23065A (en) 1989-03-27
EG17287A (en) 1993-02-28
DE3575140D1 (de) 1990-02-08
ES546377A0 (es) 1987-04-01
IE852081L (en) 1986-02-24

Similar Documents

Publication Publication Date Title
DK160098C (da) Tricycliske oxindolcarboxamid-derivater
MX154758A (es) Procedimiento para preparacion de derivados de succinimida
FI833047A (fi) Mellanprodukter foer framstaellning av omeprazol
DK0452873T3 (da) 1,8-naphthyridin-2-on-derivater
FI861262A (fi) 5- 5-(6-imidazo(1,2-a)pyridyl)pyridinderivativ.
DE69005164D1 (de) Acryloylsubstituierte Pyrrol-Derivate.
MY129935A (en) Dihydropyridine derivatives useful in antitumor therapy
ES466366A1 (es) Un procedimiento para preparar derivados de metasulfonamido-benzamida.
MX170732B (es) Composicion de derivados de succinimida y su uso
ES457805A1 (es) Un procedimiento para la preparacion de derivados de tiou- rea.
ATE140229T1 (de) Benzoxazepinon-verfahren
GR1000887B (el) Νεα παραγωγα σπιροφουρανης.
ES471208A1 (es) Procedimiento para la preparacion de nuevos derivados con- densados de pirimidina
ATE125793T1 (de) Substituierte alkensäure und ihre derivate.
ATE65986T1 (de) Propanolabkoemmlinge.
FI933468A (fi) Tetrahydronaftalenderivat, framstaellning av dessa och terapeutisk anvaendning av dessa
ES474282A1 (es) Un procedimiento para producir un compuesto de piridazinoma.

Legal Events

Date Code Title Description
PBP Patent lapsed